Jump to navigation

Home

TVG Publications

Review Articles

2011

SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools - a compass in the land of biomarker discovery
ELISPOT for measuring human immune responses to vaccines
Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
Therapeutic cancer vaccines and translating vaccinomics science to the global health clinic: Emerging applications towards proof-of-concept 
Immunologic biomarkers as correlates of clinical response to cancer immunotherapy

2010

Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force
Progress in the development of a therapeutic vaccine for breast cancer
Immune regulation of cancer

2009

FOXP3 expression and prognosis: role of both the tumor and T cells.
Use of tumour-responsive T cells as cancer treatment

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • next ›
  • last »
  • Research
    • Cancer Vaccines
    • Cancer Diagnostics
    • Immunologic Monitoring Laboratory (IML)
    • Adoptive T Cell Therapy
    • Tumor Microenvironment
    • Research Funding
  • Clinical Trials
    • Breast Cancer
    • Ovarian Cancer
    • Colon Cancer
    • Resources
    • FAQ - Clinical Trials
    • FAQ - The Immune System
    • FAQ - For Trial Participants
  • TVG In the News
  • Publications
    • Original Articles
    • Review Articles
    • Methods
    • Posters
    • Book Chapters
  • Directory
    • Principal Investigators
    • Research Staff
    • Clinical Staff
    • Administrative Staff
    • Students
    • Previous Staff Members
    • Contact Us
  • Support TVG
  • Original Articles
  • Review Articles
  • Methods
  • Posters
  • Book Chapters
Enroll in Clinical TrialsDonate NowConnect with us

Members of the Tumor Vaccine Group are faculty of UW Medicine, Seattle Cancer Care Alliance and Fred Hutchinson Cancer Research Center INTRANET   |  CONTACT US

Tumor Vaccine GroupDiscover - Translate - Cure850 Republican St., Seattle, WA 98109

Tumor Vaccine Group HomepageUW Medicine